Unity Biotechnology (UBX) SEC Filings & 10K Form

$1.53
0.00 (0.00%)
(As of 05/15/2024 ET)

Recent Unity Biotechnology SEC Filings

DateFilerForm TypeView
05/03/2024
3:05 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:20 PM
Unity Biotechnology (Filer)
Form ARS
04/26/2024
3:15 PM
Unity Biotechnology (Filer)
Form DEFA14A
04/15/2024
8:10 AM
Unity Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/15/2024
7:51 AM
Unity Biotechnology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2024
6:00 AM
Unity Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
7:00 AM
Unity Biotechnology (Filer)
Form NT 10-K
03/20/2024
3:15 PM
Unity Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
3:05 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2023
11:15 PM
Unity Biotechnology (Filer)
Form EFFECT
12/08/2023
3:39 PM
Unity Biotechnology (Filer)
Form 424B3
12/06/2023
4:25 PM
Unity Biotechnology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/13/2023
6:00 AM
Unity Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
6:05 AM
Unity Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2023
3:07 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2023
3:08 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
3:13 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
3:13 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:10 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
1:37 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2023
5:22 PM
Samuels Camille D (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
4:03 PM
Leonard Keith R (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
4:06 PM
Samar Michael P. (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
4:09 PM
Roberts Margo R (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
4:12 PM
O'Neill Gilmore Neil (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
4:12 PM
BERNS PAUL L (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
4:02 PM
David Nathaniel E (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Unity Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
4:58 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
8:25 PM
Ghosh Anirvan (Reporting)
Unity Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:UBX) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners